AroCell presents results from the U-CAN TK1 lymphoma study and from a comparison study between TK 210™ ELISA and other assays
November 27, 2018 09:00 ET | AroCell AB
AroCell’s Chief Scientific Officer, Professor Staffan Eriksson, presents today new preliminary results from the U-CAN TK1 lymphoma study at the International Society of Oncology Biomarkers (ISOBM) in...
AroCell presenterar resultat från U-CAN TK1 lymfomstudien samt från en studie där TK 210™ ELISA jämförs med andra metoder
November 27, 2018 09:00 ET | AroCell AB
I samband med ISOBMs kongress (International Society of Oncology Biomarkers) i Hamburg, presenterar idag AroCell’s forskningschef, Staffan Eriksson, nya preliminära kliniska resultat från U-CAN TK1...
Logo (3).png
Cancer Immunotherapy Market Worth $152.83 Billion by 2024 - Exclusive Report by Meticulous Research®
October 30, 2018 09:18 ET | Meticulous Market Research Pvt. Ltd.
LONDON, Oct. 30, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous Research®, the global cancer immunotherapy market is expected to grow at a CAGR of 13.8% from 2018 to...
Patent granted in the US
October 17, 2018 02:30 ET | AroCell AB
AroCell announced today that the U.S. Patent and Trademark Office has granted AroCell´s patent US 10,100,128 titled ”Monoclonal Anti-TK1 Antibodies”. The patent refers to AroCell’s...
Patent godkänt på den amerikanska marknaden
October 17, 2018 02:30 ET | AroCell AB
AroCell meddelar idag att det amerikanska patentverket har godkänt och utfärdat AroCells patent US 10,100,128 ”Monoclonal Anti-TK1 Antibodies”. Patentet avser AroCells monoklonala antikroppar...
Patent reinforces AroCell’s opportunities in the US market
August 29, 2018 09:15 ET | AroCell AB
AroCell AB has received a Notice of Allowance stating that the U.S. Patent and Trademark Office intends to grant the company's patent application no. 15/105,999 titled ”Monoclonal Anti-TK1...
Patent förstärker AroCells möjligheter på den amerikanska marknaden
August 29, 2018 09:15 ET | AroCell AB
Patent förstärker AroCells möjligheter på den amerikanska marknaden AroCell har meddelats att det amerikanska patentverket avser att godkänna bolagets patentansökan nr. 15/105,999 ”Monoclonal...
The-Business-Research-Company-horizontal-logo-2.png
The Business Research Company announces the launch of its report Global Biologics Market Opportunities And Strategies To 2022
August 22, 2018 08:00 ET | The Business Research Company
LONDON, Aug. 22, 2018 (GLOBE NEWSWIRE) -- This exciting report shows that the growth rate in the global biologics drugs market has accelerated recently and is now almost 10% year on year.   By 2022...
Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
August 15, 2018 06:00 ET | Aegis Therapeutics LLC
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....
Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
August 02, 2018 06:00 ET | Aegis Therapeutics LLC
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...